However, the data obtained in PI3Kγ genetically-deficient mice showed superimposable effects on tumor microenvironment modification and anti-tumor effector immunity observed in TG100-115 treated mice, suggesting that the anti-tumor effects of ENO1 vaccination are mainly enhanced by PI3Kγ inhibition. Here, ENO1 is linked to neoplasm.